Drugs developed by Johnson & Johnson

Drugs Developed by Johnson & Johnson

Johnson & Johnson, a multinational corporation founded in 1886, has been at the forefront of healthcare innovation for over a century. The company operates in three main sectors: Consumer Health, Medical Devices, and Pharmaceuticals. This article focuses on the pharmaceutical sector, highlighting some of the key drugs developed by Johnson & Johnson that have made significant impacts in various therapeutic areas.

Janssen Pharmaceuticals

A pivotal part of Johnson & Johnson's drug development efforts is through its subsidiary, Janssen Pharmaceuticals. Acquired in 1961, Janssen has been instrumental in researching and developing innovative medicines that address unmet medical needs.

Oncology

• Zytiga (Abiraterone acetate)

Zytiga is a medication used in the treatment of prostate cancer. It works by inhibiting the production of androgens, which can fuel the growth of prostate cancer cells.

• Imbruvica (Ibrutinib)

Imbruvica is used in the treatment of certain types of blood cancer, including chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenström's macroglobulinemia. It blocks a protein that helps cancer cells to grow and divide.

Immunology

• Stelara (Ustekinumab)

Stelara is used to treat various autoimmune diseases, including psoriasis and Crohn's disease. It works by blocking certain proteins in the body that can cause inflammation and other symptoms of autoimmune diseases.

• Tremfya (Guselkumab)

Tremfya is another drug used to treat moderate to severe plaque psoriasis. It targets a specific protein involved in the inflammatory process of psoriasis.

Infectious Diseases

• Prezista (Darunavir)

Prezista is an antiretroviral drug used in the treatment of HIV/AIDS. It works by inhibiting the action of the protease enzyme, which is essential for the replication of the HIV virus.

• Edurant (Rilpivirine)

Edurant is used in combination with other antiretroviral medications to treat HIV-1 infection in adults and children who are at least 12 years old. It works by blocking the HIV reverse transcriptase enzyme, which is involved in the replication of the virus.

Neuroscience

• Invega (Paliperidone)

Invega is an antipsychotic drug used to treat schizophrenia and schizoaffective disorder. It helps to restore the balance of neurotransmitters in the brain.

Conclusion

Johnson & Johnson, through its subsidiary Janssen Pharmaceuticals, has developed a wide range of drugs that have significantly contributed to the advancement of medical science and improved patient care in various therapeutic areas. The company continues to invest in research and development to bring new, innovative treatments to the market.